Targeting CDK12 is a novel therapeutic strategy through disrupting oncogene associated super‐enhancers in metastatic colorectal cancer
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Llyfr |
| Cyhoeddwyd: |
Wiley,
2022-12-01T00:00:00Z.
|
| Pynciau: | |
| Mynediad Ar-lein: | Connect to this object online. |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Byddwch y cyntaf i adael sylw!